Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Watson Pharma Sues FDA
Zacks
Saturday, August 18, 2012 - 4:18pm
tags:
Watson Pharmaceuticals, Actos, generics
HgCapital sells Mercury Pharma
The Deal
Saturday, August 18, 2012 - 4:15pm
tags:
Mercury Pharma
Bitter pill
Business Standard, India
Saturday, August 18, 2012 - 4:13pm
tags:
generics
Generic Market Overview: Standing at the Top of the Patent Cliff
Pharmacy Times
Saturday, August 18, 2012 - 4:12pm
tags:
generics
Pfizer, Hospira likely shoppers for Indian injectables star Agila
Fierce Pharma
Saturday, August 18, 2012 - 4:08pm
tags:
Pfizer, Hospira, Agila, Strides Arcolab
Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
PharmaLive
Saturday, August 18, 2012 - 4:07pm
tags:
Lexicon Pharmaceuticals, LX2931, rheumatoid arthritis, LX7101, glaucoma
6 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, August 18, 2012 - 4:05pm
tags:
Allergan, XenoPort, SciClone Pharmaceuticals, Acura Pharmaceuticals, Sucampo, Cumberland
AstraZeneca Wins This Summer's Pharma Acquisition Spree
Seeking Alpha
Saturday, August 18, 2012 - 4:03pm
tags:
AstraZeneca
Takeda's Actos era ends with generic launches
Fierce Pharma
Saturday, August 18, 2012 - 4:02pm
tags:
Takeda, Actos, diabetes, type 2 diabetes, generics
Focus on Nanopharmaceuticals
PharmPro
Saturday, August 18, 2012 - 4:01pm
tags:
nanoparticles, nanopharmaceuticals
Let's Only Sell High-Growth Drugs
Motley Fool
Saturday, August 18, 2012 - 3:56pm
tags:
GSK
Merck Is Overvalued
Seeking Alpha
Saturday, August 18, 2012 - 3:56pm
tags:
Merck
Merck & Co Inc (MRK): Today's Featured Drugs Laggard
The Street
Saturday, August 18, 2012 - 3:55pm
tags:
Merck
Sanofi's Auvi-Q Gets FDA Nod
Yahoo/Zacks
Saturday, August 18, 2012 - 3:54pm
tags:
Sanofi, Auvi-Q, anaphylaxis, allergic reaction
Bristol-Myers Squibb Company (BMY): Today's Featured Health Care Laggard
The Street
Saturday, August 18, 2012 - 3:52pm
tags:
Bristol-Myers Squibb
Six Disruptive Biotech Stocks
Motley Fool
Saturday, August 18, 2012 - 3:51pm
tags:
Dendreon, Seattle Genetics, Immunogen, Roche, Vertex Pharmaceuticals, Aveo, Ariad Pharmaceuticals, Isis Pharmaceuticals
Healthcare Biz Recap: Vivus’ PATENT Problem, Idenix Survives Clinical HOLD
Wall Street Cheat Street
Saturday, August 18, 2012 - 3:48pm
tags:
Vivus, generics, Qsymia, Idenix, Pluristem Therapeutics
The Rosen Law Firm Reminds Investors of Important August 31, 2012 Deadline in Securities Class Action Against PolyMedix, Inc.
Yahoo/GlobeNewsWire
Saturday, August 18, 2012 - 3:46pm
tags:
PolyMedix, lawsuits
Idenix Pharmaceuticals' CEO Provides Update on IDX184 Clinical Development Program Conference (Transcript)
Seeking Alpha
Saturday, August 18, 2012 - 3:39pm
tags:
Idenix, IDX184, HCV
Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics
Yahoo/BusinessWire
Saturday, August 18, 2012 - 3:37pm
tags:
Allos, Spectrum Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.